Inl Med - Endcrn Diabetes Clin

Research Output

Filter
Comment/debate
2019

Erratum: Baseline characteristics of the Vitamin D and type 2 diabetes (D2D) study: A contemporary prediabetes cohort that will inform diabetes prevention efforts (Diabetes Care (2018) 41 (1590–1599) DOI: 10.2337/dc18-0240)

LeBlanc, E. S., Pratley, R. E., Dawson-Hughes, B., Staten, M. A., Sheehan, P. R., Lewis, M. R., Peters, A., Kim, S. H., Chatterjee, R., Aroda, V. R., Chadha, C., Neff, L. M., Brodsky, I. G., Rosen, C., Desouza, C. V., Foreyt, J. P., Hsia, D. S., Johnson, K. C., Raskin, P., Kashyap, S. R. & 6 others, O’Neil, P., Phillips, L. S., Rasouli, N., Liao, E. P., Robbins, D. C. & Pittas, A. G., Dec 1 2019, In : Diabetes care. 42, 12, 1 p.

Research output: Contribution to journalComment/debate

Open Access
2015

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomized, double-blind, placebo-controlled phase 2 trial

Rigby, M. R., DiMeglio, L. A., Rendell, M. S., Felner, E. I., Dostou, J. M., Gitelman, S. E., Patel, C. M., Griffin, K. J., Tsalikian, E., Gottlieb, P. A., Greenbaum, C. J., Sherry, N. A., Moore, W. V., Monzavi, R., Willi, S. M., Raskin, P., Moran, A., Russell, W. E., Pinckney, A., Keyes-Elstein, L. & 7 others, Howell, M., Aggarwal, S., Lim, N., Phippard, D., Nepom, G. T., McNamara, J. & Ehlers, M. R., Feb 1 2015, In : Diabetes Technology and Therapeutics. 17, p. S81-S82

Research output: Contribution to journalComment/debate

2014

Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

Moran, A., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Greenbaum, C. J., Herold, K. C., Marks, J. B., Raskin, P., Sanda, S., Schatz, D., Wherrett, D., Wilson, D. M., Krischer, J. P., Skyler, J. S., Pickersgill, L., De Koning, E., Ziegler, A. G., Böehm, B. & 11 others, Badenhoop, K., Schloot, N., Bak, J. F., Pozzilli, P., Mauricio, D., Donath, M. Y., Castaño, L., Wägner, A., Lervang, H. H., Perrild, H. & Mandrup-Poulsen, T., Feb 10 2014, In : Diabetes Technology and Therapeutics. 16, SUPPL. 1, p. S87

Research output: Contribution to journalComment/debate

2013

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recentonset type 1 diabetes: A randomized double-blind trial

Wherrett, D. K., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Marks, J. B., Monzavi, R., Moran, A., Orban, T., Palmer, J. P., Raskin, P., Rodriguez, H., Schatz, D., Wilson, D. M., Krischer, J. P. & Skyler, J. S., Jun 1 2013, In : Diabetes Technology and Therapeutics. 15, SUPPL.1, p. S115-S116

Research output: Contribution to journalComment/debate

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere insulin or usual antidiabetes treatment: A randomized trial

Raskin, P., Heller, S., Honka, M., Chang, P. C., Boss, A. H., Richardson, P. C. & Amin, N., Jun 1 2013, In : Diabetes Technology and Therapeutics. 15, SUPPL.1, p. S56

Research output: Contribution to journalComment/debate

2010

Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)

Raskin, P. & Mohan, A., Sep 1 2010, In : Expert Opinion on Pharmacotherapy. 11, 13, p. 2269-2271 3 p.

Research output: Contribution to journalComment/debate

8 Scopus citations

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230))

Zinman, B., Gerich, J., Buse, J. B., Lewin, A., Schwartz, S., Raskin, P., Hale, P. M., Zdravkovic, M. & Blonde, L., Mar 1 2010, In : Diabetes care. 33, 3, 1 p.

Research output: Contribution to journalComment/debate

7 Scopus citations
2003

Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

Raskin, P., Klaff, L., McGill, J., South, S. A., Hollander, P., Khutoryansky, N. & Hale, P. M., Sep 1 2003, In : Diabetes care. 26, 9, 1 p.

Research output: Contribution to journalComment/debate

2001

Idiopathic type 1 diabetes in Dallas.

Piñero-Piloña, A., Litonjua, P., Aviles-Santa, L. & Raskin, P., Nov 2001, In : Diabetes care. 24, 11, 1 p.

Research output: Contribution to journalComment/debate

Open Access
1992

Tight glycemic control? Negative.

Raskin, P., Feb 1 1992, In : Hospital practice (Office ed.). 27 Suppl 1, p. 21-24 4 p.

Research output: Contribution to journalComment/debate